A detailed history of Ifg Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ifg Advisors, LLC holds 861 shares of LLY stock, worth $694,086. This represents 0.17% of its overall portfolio holdings.

Number of Shares
861
Previous 795 8.3%
Holding current value
$694,086
Previous $719,000 5.98%
% of portfolio
0.17%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$772.14 - $960.02 $50,961 - $63,361
66 Added 8.3%
861 $762,000
Q1 2024

Apr 24, 2024

BUY
$592.2 - $792.28 $38,493 - $51,498
65 Added 8.9%
795 $618,000
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $39,914 - $47,053
76 Added 11.62%
730 $425,000
Q2 2023

Jul 18, 2023

BUY
$350.74 - $468.98 $8,417 - $11,255
24 Added 3.81%
654 $306,000
Q3 2022

Nov 02, 2022

BUY
$296.48 - $337.87 $186,782 - $212,858
630 New
630 $204,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ifg Advisors, LLC Portfolio

Follow Ifg Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisors, LLC with notifications on news.